Genetic Tech Ltd.-SP ADRGENE
13F holders, Q3 2025 (September 30)2holders +1
1new positions
0sold out
$0.76avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Genetic Tech Ltd.-SP ADR (GENE) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Rhumbline Advisers ($2K) and Bessemer Group Inc. ($0).
- Company
- Genetic Tech Ltd.-SP ADR
- CUSIP
- 37185R406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 24 shares bought and 690 shares sold, net −666 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rhumbline Advisers | 0.00% | Reduce -20.7% | 2,650 | $2K |
| Bessemer Group Inc. | 0.00% | New | 24 | $0 |
"% of holder's portfolio" is GENE's weight in each manager's 13F, not the share of Genetic Tech Ltd.-SP ADR the manager owns.